Molecular network boosts drug resistance and virulence in hospital-acquired bacterium

May 24, 2018

In response to antibiotics, a gene regulation network found in the bacterium Acinetobacter baumannii acts to boost both virulence and antibiotic resistance. Edward Geisinger of Tufts University School of Medicine and colleagues present new insights into this system in a study published in PLOS Pathogens.

A. baumannii is a multi-drug resistant bacterium that spreads in hospitals around the world, causing serious infections such as pneumonia, wound infection, and sepsis. Previous research has shown that the bacterium's BfmRS system, a network of molecules that influence gene expression, enables it to build a protective capsule around itself in response to attack with antibiotics.

Despite the importance of BfmRS, its precise role in regulation of gene expression in the bacterium, and the resulting influence on the ability of A. baumannii to resist antibiotics and cause disease, have been unclear. In the new study, Geisinger and colleagues performed a series of experiments to clarify the role of BfmRS.

Using strains of A. baumannii that were genetically altered to either activate or wipe out the BfmRS stress response, the researchers showed that BfmRS enables lethal sepsis in mice. They also tested how these strains responded to antibiotic exposure, finding that the BfmRS stress response confers resistance to a wide variety of drugs.

The research team also showed that these effects are connected to the genetic influence of BfmRS, demonstrating through RNA sequencing experiments that it can reprogram gene expression throughout the A. baumannii genome. In particular, BfmRS controls a variety of genetic pathways involved in construction and integrity of multiple components of the cell envelope as well as cell division.

In a final experiment, the scientists showed that mutations to enhance antibiotic resistance could bypass the need for BfmRS in an A. baumannii strain in which BfmRS had been wiped out. These mutations also impacted processes that influence the cell envelope and division, highlighting the link between drug resistance and cell physiology.

Together, these findings show that BfmRS plays a central coordinating role in the intertwined ability of A. baumannii to resist antibiotics and boost virulence in response to them. This suggests that inhibition of BfmRS could serve as a potential strategy to combat A. baumannii.

"We revealed that a single two-protein system controls a global network of proteins that is critical for making A. baumannii a threat," the authors further explain. "These proteins control broad drug resistance and the potential to cause opportunistic disease, and center on processes that build and maintain the cell envelope."
In your coverage please use this URL to provide access to the freely available article in PLOS Pathogens:

Citation: Geisinger E, Mortman NJ, Vargas-Cuebas G, Tai AK, Isberg RR (2018) A global regulatory system links virulence and antibiotic resistance to envelope homeostasis in Acinetobacter baumannii. PLoS Pathog 14(5): e1007030.

Funding: The National Institute of Allergy and Infectious Diseases supported the work performed by RRI (01 AI124302, R21 AI128328), NJM (U01 AI124302), and EG (U01 AI124302 and F32 AI098358). The National Institute of General Medical Sciences supported the work performed by GV-C (R25 GM066567). HHMI also supported the work by RRI, EG, and GV-C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests: The authors have declared that no competing interests exist.


Related Antibiotics Articles from Brightsurf:

Insights in the search for new antibiotics
A collaborative research team from the University of Oklahoma, the Memorial Sloan Kettering Cancer Center and Merck & Co. published an opinion article in the journal, Nature Chemical Biology, that addresses the gap in the discovery of new antibiotics.

New tricks for old antibiotics
The study published in the journal Immunity reveals that tetracyclines (broad spectre antibiotics), by partially inhibiting cell mitochondria activity, induce a compensatory response on the organism that decreases tissue damage caused during infection.

Benefits, risks seen with antibiotics-first for appendicitis
Antibiotics are a good choice for some patients with appendicitis but not all, according to study results published today in the New England Journal of Medicine.

How antibiotics interact
Understanding bottleneck effects in the translation of bacterial proteins can lead to a more effective combination of antibiotics / study in 'Nature Communications'

Are antivitamins the new antibiotics?
Antibiotics are among the most important discoveries of modern medicine and have saved millions of lives since the discovery of penicillin almost 100 years ago.

Hygiene reduces the need for antibiotics by up to 30%
A new paper published in the American Journal of Infection Control (AJIC), finds improved everyday hygiene practices, such as hand-washing, reduces the risk of common infections by up to 50%, reducing the need for antibiotics, by up to 30%.

Antibiotics: City dwellers and children take the most
City dwellers take more antibiotics than people in rural areas; children and the elderly use them more often than middle-aged people; the use of antibiotics decreases as education increases, but only in rich countries: These are three of the more striking trends identified by researchers of the NRW Forschungskolleg ''One Health and Urban Transformation'' at the University of Bonn.

Metals could be the link to new antibiotics
Compounds containing metals could hold the key to the next generation of antibiotics to combat the growing threat of global antibiotic resistance.

Antibiotics from the sea
The team led by Prof. Christian Jogler of Friedrich Schiller University, Jena, has succeeded in cultivating several dozen marine bacteria in the laboratory -- bacteria that had previously been paid little attention.

Antibiotics not necessary for most toothaches, according to new ADA guideline
The American Dental Association (ADA) announced today a new guideline indicating that in most cases, antibiotics are not recommended for toothaches.

Read More: Antibiotics News and Antibiotics Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to